Global Oncolytic Virus Drug Treatment Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Page: 101

Published Date: 17 May 2022

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The Oncolytic Virus Drug Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Oncolytic Virus Drug Treatment market size is estimated to be worth US$  million in 2021 and is forecast to a readjusted size of USD  million by 2028 with a CAGR of  % during forecast period 2022-2028. Melanoma accounting for  % of the Oncolytic Virus Drug Treatment global market in 2021, is projected to value USD  million by 2028, growing at a  % CAGR in next six years. While Phase 1 segment is altered to a  % CAGR between 2022 and 2028.

Global key companies of Oncolytic Virus Drug Treatment include Amgen, Oncolytics Biotech, Viralytics, Transgene SA, and Oncolys BioPharma, etc. In terms of revenue, the global top four players hold a share over  % in 2021.

Market segmentation
Oncolytic Virus Drug Treatment market is split by Clinical Stage and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Clinical Stage and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Clinical Stage, covers
    Phase 1
    Phase 2
    Others

Market segment by Application, can be divided into
    Melanoma
    Prostate Cancer
    Breast Cancer
    Ovarian Cancer
    Others

Market segment by players, this report covers
    Amgen
    Oncolytics Biotech
    Viralytics
    Transgene SA
    Oncolys BioPharma
    Targovax
    PsiOxus Therapeutics
    SillaJen Biotherapeutics
    Sorrento Therapeutics
    Lokon Pharma
    Genelux Corporation
    Vyriad
    TILT Biotherapeutics
    Cold Genesys

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Oncolytic Virus Drug Treatment product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Oncolytic Virus Drug Treatment, with revenue, gross margin and global market share of Oncolytic Virus Drug Treatment from 2019 to 2022.
Chapter 3, the Oncolytic Virus Drug Treatment competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Clinical Stage and application, with revenue and growth rate by Clinical Stage, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Oncolytic Virus Drug Treatment market forecast, by regions, clinical stage and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Oncolytic Virus Drug Treatment research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Oncolytic Virus Drug Treatment
    1.2 Classification of Oncolytic Virus Drug Treatment by Clinical Stage
        1.2.1 Overview: Global Oncolytic Virus Drug Treatment Market Size by Clinical Stage: 2017 Versus 2021 Versus 2028
        1.2.2 Global Oncolytic Virus Drug Treatment Revenue Market Share by Clinical Stage in 2021
        1.2.3 Phase 1
        1.2.4 Phase 2
        1.2.5 Others
    1.3 Global Oncolytic Virus Drug Treatment Market by Application
        1.3.1 Overview: Global Oncolytic Virus Drug Treatment Market Size by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Melanoma
        1.3.3 Prostate Cancer
        1.3.4 Breast Cancer
        1.3.5 Ovarian Cancer
        1.3.6 Others
    1.4 Global Oncolytic Virus Drug Treatment Market Size & Forecast
    1.5 Global Oncolytic Virus Drug Treatment Market Size and Forecast by Region
        1.5.1 Global Oncolytic Virus Drug Treatment Market Size by Region: 2017 VS 2021 VS 2028
        1.5.2 Global Oncolytic Virus Drug Treatment Market Size by Region, (2017-2022)
        1.5.3 North America Oncolytic Virus Drug Treatment Market Size and Prospect (2017-2028)
        1.5.4 Europe Oncolytic Virus Drug Treatment Market Size and Prospect (2017-2028)
        1.5.5 Asia-Pacific Oncolytic Virus Drug Treatment Market Size and Prospect (2017-2028)
        1.5.6 South America Oncolytic Virus Drug Treatment Market Size and Prospect (2017-2028)
        1.5.7 Middle East and Africa Oncolytic Virus Drug Treatment Market Size and Prospect (2017-2028)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Oncolytic Virus Drug Treatment Market Drivers
        1.6.2 Oncolytic Virus Drug Treatment Market Restraints
        1.6.3 Oncolytic Virus Drug Treatment Trends Analysis

2 Company Profiles
    2.1 Amgen
        2.1.1 Amgen Details
        2.1.2 Amgen Major Business
        2.1.3 Amgen Oncolytic Virus Drug Treatment Product and Solutions
        2.1.4 Amgen Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.1.5 Amgen Recent Developments and Future Plans
    2.2 Oncolytics Biotech
        2.2.1 Oncolytics Biotech Details
        2.2.2 Oncolytics Biotech Major Business
        2.2.3 Oncolytics Biotech Oncolytic Virus Drug Treatment Product and Solutions
        2.2.4 Oncolytics Biotech Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.2.5 Oncolytics Biotech Recent Developments and Future Plans
    2.3 Viralytics
        2.3.1 Viralytics Details
        2.3.2 Viralytics Major Business
        2.3.3 Viralytics Oncolytic Virus Drug Treatment Product and Solutions
        2.3.4 Viralytics Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.3.5 Viralytics Recent Developments and Future Plans
    2.4 Transgene SA
        2.4.1 Transgene SA Details
        2.4.2 Transgene SA Major Business
        2.4.3 Transgene SA Oncolytic Virus Drug Treatment Product and Solutions
        2.4.4 Transgene SA Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.4.5 Transgene SA Recent Developments and Future Plans
    2.5 Oncolys BioPharma
        2.5.1 Oncolys BioPharma Details
        2.5.2 Oncolys BioPharma Major Business
        2.5.3 Oncolys BioPharma Oncolytic Virus Drug Treatment Product and Solutions
        2.5.4 Oncolys BioPharma Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.5.5 Oncolys BioPharma Recent Developments and Future Plans
    2.6 Targovax
        2.6.1 Targovax Details
        2.6.2 Targovax Major Business
        2.6.3 Targovax Oncolytic Virus Drug Treatment Product and Solutions
        2.6.4 Targovax Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.6.5 Targovax Recent Developments and Future Plans
    2.7 PsiOxus Therapeutics
        2.7.1 PsiOxus Therapeutics Details
        2.7.2 PsiOxus Therapeutics Major Business
        2.7.3 PsiOxus Therapeutics Oncolytic Virus Drug Treatment Product and Solutions
        2.7.4 PsiOxus Therapeutics Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.7.5 PsiOxus Therapeutics Recent Developments and Future Plans
    2.8 SillaJen Biotherapeutics
        2.8.1 SillaJen Biotherapeutics Details
        2.8.2 SillaJen Biotherapeutics Major Business
        2.8.3 SillaJen Biotherapeutics Oncolytic Virus Drug Treatment Product and Solutions
        2.8.4 SillaJen Biotherapeutics Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.8.5 SillaJen Biotherapeutics Recent Developments and Future Plans
    2.9 Sorrento Therapeutics
        2.9.1 Sorrento Therapeutics Details
        2.9.2 Sorrento Therapeutics Major Business
        2.9.3 Sorrento Therapeutics Oncolytic Virus Drug Treatment Product and Solutions
        2.9.4 Sorrento Therapeutics Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.9.5 Sorrento Therapeutics Recent Developments and Future Plans
    2.10 Lokon Pharma
        2.10.1 Lokon Pharma Details
        2.10.2 Lokon Pharma Major Business
        2.10.3 Lokon Pharma Oncolytic Virus Drug Treatment Product and Solutions
        2.10.4 Lokon Pharma Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.10.5 Lokon Pharma Recent Developments and Future Plans
    2.11 Genelux Corporation
        2.11.1 Genelux Corporation Details
        2.11.2 Genelux Corporation Major Business
        2.11.3 Genelux Corporation Oncolytic Virus Drug Treatment Product and Solutions
        2.11.4 Genelux Corporation Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.11.5 Genelux Corporation Recent Developments and Future Plans
    2.12 Vyriad
        2.12.1 Vyriad Details
        2.12.2 Vyriad Major Business
        2.12.3 Vyriad Oncolytic Virus Drug Treatment Product and Solutions
        2.12.4 Vyriad Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.12.5 Vyriad Recent Developments and Future Plans
    2.13 TILT Biotherapeutics
        2.13.1 TILT Biotherapeutics Details
        2.13.2 TILT Biotherapeutics Major Business
        2.13.3 TILT Biotherapeutics Oncolytic Virus Drug Treatment Product and Solutions
        2.13.4 TILT Biotherapeutics Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.13.5 TILT Biotherapeutics Recent Developments and Future Plans
    2.14 Cold Genesys
        2.14.1 Cold Genesys Details
        2.14.2 Cold Genesys Major Business
        2.14.3 Cold Genesys Oncolytic Virus Drug Treatment Product and Solutions
        2.14.4 Cold Genesys Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.14.5 Cold Genesys Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Oncolytic Virus Drug Treatment Revenue and Share by Players (2019, 2020, 2021, and 2022)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Oncolytic Virus Drug Treatment Players Market Share in 2021
        3.2.2 Top 10 Oncolytic Virus Drug Treatment Players Market Share in 2021
        3.2.3 Market Competition Trend
    3.3 Oncolytic Virus Drug Treatment Players Head Office, Products and Services Provided
    3.4 Oncolytic Virus Drug Treatment Mergers & Acquisitions
    3.5 Oncolytic Virus Drug Treatment New Entrants and Expansion Plans

4 Market Size Segment by Clinical Stage
    4.1 Global Oncolytic Virus Drug Treatment Revenue and Market Share by Clinical Stage (2017-2022)
    4.2 Global Oncolytic Virus Drug Treatment Market Forecast by Clinical Stage (2023-2028)

5 Market Size Segment by Application
    5.1 Global Oncolytic Virus Drug Treatment Revenue Market Share by Application (2017-2022)
    5.2 Global Oncolytic Virus Drug Treatment Market Forecast by Application (2023-2028)

6 North America by Country, by Clinical Stage, and by Application
    6.1 North America Oncolytic Virus Drug Treatment Revenue by Clinical Stage (2017-2028)
    6.2 North America Oncolytic Virus Drug Treatment Revenue by Application (2017-2028)
    6.3 North America Oncolytic Virus Drug Treatment Market Size by Country
        6.3.1 North America Oncolytic Virus Drug Treatment Revenue by Country (2017-2028)
        6.3.2 United States Oncolytic Virus Drug Treatment Market Size and Forecast (2017-2028)
        6.3.3 Canada Oncolytic Virus Drug Treatment Market Size and Forecast (2017-2028)
        6.3.4 Mexico Oncolytic Virus Drug Treatment Market Size and Forecast (2017-2028)

7 Europe by Country, by Clinical Stage, and by Application
    7.1 Europe Oncolytic Virus Drug Treatment Revenue by Clinical Stage (2017-2028)
    7.2 Europe Oncolytic Virus Drug Treatment Revenue by Application (2017-2028)
    7.3 Europe Oncolytic Virus Drug Treatment Market Size by Country
        7.3.1 Europe Oncolytic Virus Drug Treatment Revenue by Country (2017-2028)
        7.3.2 Germany Oncolytic Virus Drug Treatment Market Size and Forecast (2017-2028)
        7.3.3 France Oncolytic Virus Drug Treatment Market Size and Forecast (2017-2028)
        7.3.4 United Kingdom Oncolytic Virus Drug Treatment Market Size and Forecast (2017-2028)
        7.3.5 Russia Oncolytic Virus Drug Treatment Market Size and Forecast (2017-2028)
        7.3.6 Italy Oncolytic Virus Drug Treatment Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Clinical Stage, and by Application
    8.1 Asia-Pacific Oncolytic Virus Drug Treatment Revenue by Clinical Stage (2017-2028)
    8.2 Asia-Pacific Oncolytic Virus Drug Treatment Revenue by Application (2017-2028)
    8.3 Asia-Pacific Oncolytic Virus Drug Treatment Market Size by Region
        8.3.1 Asia-Pacific Oncolytic Virus Drug Treatment Revenue by Region (2017-2028)
        8.3.2 China Oncolytic Virus Drug Treatment Market Size and Forecast (2017-2028)
        8.3.3 Japan Oncolytic Virus Drug Treatment Market Size and Forecast (2017-2028)
        8.3.4 South Korea Oncolytic Virus Drug Treatment Market Size and Forecast (2017-2028)
        8.3.5 India Oncolytic Virus Drug Treatment Market Size and Forecast (2017-2028)
        8.3.6 Southeast Asia Oncolytic Virus Drug Treatment Market Size and Forecast (2017-2028)
        8.3.7 Australia Oncolytic Virus Drug Treatment Market Size and Forecast (2017-2028)

9 South America by Country, by Clinical Stage, and by Application
    9.1 South America Oncolytic Virus Drug Treatment Revenue by Clinical Stage (2017-2028)
    9.2 South America Oncolytic Virus Drug Treatment Revenue by Application (2017-2028)
    9.3 South America Oncolytic Virus Drug Treatment Market Size by Country
        9.3.1 South America Oncolytic Virus Drug Treatment Revenue by Country (2017-2028)
        9.3.2 Brazil Oncolytic Virus Drug Treatment Market Size and Forecast (2017-2028)
        9.3.3 Argentina Oncolytic Virus Drug Treatment Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Clinical Stage, and by Application
    10.1 Middle East & Africa Oncolytic Virus Drug Treatment Revenue by Clinical Stage (2017-2028)
    10.2 Middle East & Africa Oncolytic Virus Drug Treatment Revenue by Application (2017-2028)
    10.3 Middle East & Africa Oncolytic Virus Drug Treatment Market Size by Country
        10.3.1 Middle East & Africa Oncolytic Virus Drug Treatment Revenue by Country (2017-2028)
        10.3.2 Turkey Oncolytic Virus Drug Treatment Market Size and Forecast (2017-2028)
        10.3.3 Saudi Arabia Oncolytic Virus Drug Treatment Market Size and Forecast (2017-2028)
        10.3.4 UAE Oncolytic Virus Drug Treatment Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Oncolytic Virus Drug Treatment Revenue by Clinical Stage, (USD Million), 2017 VS 2021 VS 2028
    Table 2. Global Oncolytic Virus Drug Treatment Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
    Table 3. Global Market Oncolytic Virus Drug Treatment Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
    Table 4. Global Oncolytic Virus Drug Treatment Revenue (USD Million) by Region (2017-2022)
    Table 5. Global Oncolytic Virus Drug Treatment Revenue Market Share by Region (2023-2028)
    Table 6. Amgen Corporate Information, Head Office, and Major Competitors
    Table 7. Amgen Major Business
    Table 8. Amgen Oncolytic Virus Drug Treatment Product and Solutions
    Table 9. Amgen Oncolytic Virus Drug Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 10. Oncolytics Biotech Corporate Information, Head Office, and Major Competitors
    Table 11. Oncolytics Biotech Major Business
    Table 12. Oncolytics Biotech Oncolytic Virus Drug Treatment Product and Solutions
    Table 13. Oncolytics Biotech Oncolytic Virus Drug Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 14. Viralytics Corporate Information, Head Office, and Major Competitors
    Table 15. Viralytics Major Business
    Table 16. Viralytics Oncolytic Virus Drug Treatment Product and Solutions
    Table 17. Viralytics Oncolytic Virus Drug Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 18. Transgene SA Corporate Information, Head Office, and Major Competitors
    Table 19. Transgene SA Major Business
    Table 20. Transgene SA Oncolytic Virus Drug Treatment Product and Solutions
    Table 21. Transgene SA Oncolytic Virus Drug Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 22. Oncolys BioPharma Corporate Information, Head Office, and Major Competitors
    Table 23. Oncolys BioPharma Major Business
    Table 24. Oncolys BioPharma Oncolytic Virus Drug Treatment Product and Solutions
    Table 25. Oncolys BioPharma Oncolytic Virus Drug Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 26. Targovax Corporate Information, Head Office, and Major Competitors
    Table 27. Targovax Major Business
    Table 28. Targovax Oncolytic Virus Drug Treatment Product and Solutions
    Table 29. Targovax Oncolytic Virus Drug Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 30. PsiOxus Therapeutics Corporate Information, Head Office, and Major Competitors
    Table 31. PsiOxus Therapeutics Major Business
    Table 32. PsiOxus Therapeutics Oncolytic Virus Drug Treatment Product and Solutions
    Table 33. PsiOxus Therapeutics Oncolytic Virus Drug Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 34. SillaJen Biotherapeutics Corporate Information, Head Office, and Major Competitors
    Table 35. SillaJen Biotherapeutics Major Business
    Table 36. SillaJen Biotherapeutics Oncolytic Virus Drug Treatment Product and Solutions
    Table 37. SillaJen Biotherapeutics Oncolytic Virus Drug Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 38. Sorrento Therapeutics Corporate Information, Head Office, and Major Competitors
    Table 39. Sorrento Therapeutics Major Business
    Table 40. Sorrento Therapeutics Oncolytic Virus Drug Treatment Product and Solutions
    Table 41. Sorrento Therapeutics Oncolytic Virus Drug Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 42. Lokon Pharma Corporate Information, Head Office, and Major Competitors
    Table 43. Lokon Pharma Major Business
    Table 44. Lokon Pharma Oncolytic Virus Drug Treatment Product and Solutions
    Table 45. Lokon Pharma Oncolytic Virus Drug Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 46. Genelux Corporation Corporate Information, Head Office, and Major Competitors
    Table 47. Genelux Corporation Major Business
    Table 48. Genelux Corporation Oncolytic Virus Drug Treatment Product and Solutions
    Table 49. Genelux Corporation Oncolytic Virus Drug Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 50. Vyriad Corporate Information, Head Office, and Major Competitors
    Table 51. Vyriad Major Business
    Table 52. Vyriad Oncolytic Virus Drug Treatment Product and Solutions
    Table 53. Vyriad Oncolytic Virus Drug Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 54. TILT Biotherapeutics Corporate Information, Head Office, and Major Competitors
    Table 55. TILT Biotherapeutics Major Business
    Table 56. TILT Biotherapeutics Oncolytic Virus Drug Treatment Product and Solutions
    Table 57. TILT Biotherapeutics Oncolytic Virus Drug Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 58. Cold Genesys Corporate Information, Head Office, and Major Competitors
    Table 59. Cold Genesys Major Business
    Table 60. Cold Genesys Oncolytic Virus Drug Treatment Product and Solutions
    Table 61. Cold Genesys Oncolytic Virus Drug Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 62. Global Oncolytic Virus Drug Treatment Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
    Table 63. Global Oncolytic Virus Drug Treatment Revenue Share by Players (2019, 2020, 2021, and 2022)
    Table 64. Breakdown of Oncolytic Virus Drug Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
    Table 65. Oncolytic Virus Drug Treatment Players Head Office, Products and Services Provided
    Table 66. Oncolytic Virus Drug Treatment Mergers & Acquisitions in the Past Five Years
    Table 67. Oncolytic Virus Drug Treatment New Entrants and Expansion Plans
    Table 68. Global Oncolytic Virus Drug Treatment Revenue (USD Million) by Clinical Stage (2017-2022)
    Table 69. Global Oncolytic Virus Drug Treatment Revenue Share by Clinical Stage (2017-2022)
    Table 70. Global Oncolytic Virus Drug Treatment Revenue Forecast by Clinical Stage (2023-2028)
    Table 71. Global Oncolytic Virus Drug Treatment Revenue by Application (2017-2022)
    Table 72. Global Oncolytic Virus Drug Treatment Revenue Forecast by Application (2023-2028)
    Table 73. North America Oncolytic Virus Drug Treatment Revenue by Clinical Stage (2017-2022) & (USD Million)
    Table 74. North America Oncolytic Virus Drug Treatment Revenue by Clinical Stage (2023-2028) & (USD Million)
    Table 75. North America Oncolytic Virus Drug Treatment Revenue by Application (2017-2022) & (USD Million)
    Table 76. North America Oncolytic Virus Drug Treatment Revenue by Application (2023-2028) & (USD Million)
    Table 77. North America Oncolytic Virus Drug Treatment Revenue by Country (2017-2022) & (USD Million)
    Table 78. North America Oncolytic Virus Drug Treatment Revenue by Country (2023-2028) & (USD Million)
    Table 79. Europe Oncolytic Virus Drug Treatment Revenue by Clinical Stage (2017-2022) & (USD Million)
    Table 80. Europe Oncolytic Virus Drug Treatment Revenue by Clinical Stage (2023-2028) & (USD Million)
    Table 81. Europe Oncolytic Virus Drug Treatment Revenue by Application (2017-2022) & (USD Million)
    Table 82. Europe Oncolytic Virus Drug Treatment Revenue by Application (2023-2028) & (USD Million)
    Table 83. Europe Oncolytic Virus Drug Treatment Revenue by Country (2017-2022) & (USD Million)
    Table 84. Europe Oncolytic Virus Drug Treatment Revenue by Country (2023-2028) & (USD Million)
    Table 85. Asia-Pacific Oncolytic Virus Drug Treatment Revenue by Clinical Stage (2017-2022) & (USD Million)
    Table 86. Asia-Pacific Oncolytic Virus Drug Treatment Revenue by Clinical Stage (2023-2028) & (USD Million)
    Table 87. Asia-Pacific Oncolytic Virus Drug Treatment Revenue by Application (2017-2022) & (USD Million)
    Table 88. Asia-Pacific Oncolytic Virus Drug Treatment Revenue by Application (2023-2028) & (USD Million)
    Table 89. Asia-Pacific Oncolytic Virus Drug Treatment Revenue by Region (2017-2022) & (USD Million)
    Table 90. Asia-Pacific Oncolytic Virus Drug Treatment Revenue by Region (2023-2028) & (USD Million)
    Table 91. South America Oncolytic Virus Drug Treatment Revenue by Clinical Stage (2017-2022) & (USD Million)
    Table 92. South America Oncolytic Virus Drug Treatment Revenue by Clinical Stage (2023-2028) & (USD Million)
    Table 93. South America Oncolytic Virus Drug Treatment Revenue by Application (2017-2022) & (USD Million)
    Table 94. South America Oncolytic Virus Drug Treatment Revenue by Application (2023-2028) & (USD Million)
    Table 95. South America Oncolytic Virus Drug Treatment Revenue by Country (2017-2022) & (USD Million)
    Table 96. South America Oncolytic Virus Drug Treatment Revenue by Country (2023-2028) & (USD Million)
    Table 97. Middle East & Africa Oncolytic Virus Drug Treatment Revenue by Clinical Stage (2017-2022) & (USD Million)
    Table 98. Middle East & Africa Oncolytic Virus Drug Treatment Revenue by Clinical Stage (2023-2028) & (USD Million)
    Table 99. Middle East & Africa Oncolytic Virus Drug Treatment Revenue by Application (2017-2022) & (USD Million)
    Table 100. Middle East & Africa Oncolytic Virus Drug Treatment Revenue by Application (2023-2028) & (USD Million)
    Table 101. Middle East & Africa Oncolytic Virus Drug Treatment Revenue by Country (2017-2022) & (USD Million)
    Table 102. Middle East & Africa Oncolytic Virus Drug Treatment Revenue by Country (2023-2028) & (USD Million)
List of Figures
    Figure 1. Oncolytic Virus Drug Treatment Picture
    Figure 2. Global Oncolytic Virus Drug Treatment Revenue Market Share by Clinical Stage in 2021
    Figure 3. Phase 1
    Figure 4. Phase 2
    Figure 5. Others
    Figure 6. Oncolytic Virus Drug Treatment Revenue Market Share by Application in 2021
    Figure 7. Melanoma Picture
    Figure 8. Prostate Cancer Picture
    Figure 9. Breast Cancer Picture
    Figure 10. Ovarian Cancer Picture
    Figure 11. Others Picture
    Figure 12. Global Oncolytic Virus Drug Treatment Market Size, (USD Million): 2017 VS 2021 VS 2028
    Figure 13. Global Oncolytic Virus Drug Treatment Revenue and Forecast (2017-2028) & (USD Million)
    Figure 14. Global Oncolytic Virus Drug Treatment Revenue Market Share by Region (2017-2028)
    Figure 15. Global Oncolytic Virus Drug Treatment Revenue Market Share by Region in 2021
    Figure 16. North America Oncolytic Virus Drug Treatment Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 17. Europe Oncolytic Virus Drug Treatment Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 18. Asia-Pacific Oncolytic Virus Drug Treatment Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 19. South America Oncolytic Virus Drug Treatment Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 20. Middle East and Africa Oncolytic Virus Drug Treatment Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 21. Oncolytic Virus Drug Treatment Market Drivers
    Figure 22. Oncolytic Virus Drug Treatment Market Restraints
    Figure 23. Oncolytic Virus Drug Treatment Market Trends
    Figure 24. Amgen Recent Developments and Future Plans
    Figure 25. Oncolytics Biotech Recent Developments and Future Plans
    Figure 26. Viralytics Recent Developments and Future Plans
    Figure 27. Transgene SA Recent Developments and Future Plans
    Figure 28. Oncolys BioPharma Recent Developments and Future Plans
    Figure 29. Targovax Recent Developments and Future Plans
    Figure 30. PsiOxus Therapeutics Recent Developments and Future Plans
    Figure 31. SillaJen Biotherapeutics Recent Developments and Future Plans
    Figure 32. Sorrento Therapeutics Recent Developments and Future Plans
    Figure 33. Lokon Pharma Recent Developments and Future Plans
    Figure 34. Genelux Corporation Recent Developments and Future Plans
    Figure 35. Vyriad Recent Developments and Future Plans
    Figure 36. TILT Biotherapeutics Recent Developments and Future Plans
    Figure 37. Cold Genesys Recent Developments and Future Plans
    Figure 38. Global Oncolytic Virus Drug Treatment Revenue Share by Players in 2021
    Figure 39. Oncolytic Virus Drug Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
    Figure 40. Global Top 3 Players Oncolytic Virus Drug Treatment Revenue Market Share in 2021
    Figure 41. Global Top 10 Players Oncolytic Virus Drug Treatment Revenue Market Share in 2021
    Figure 42. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
    Figure 43. Global Oncolytic Virus Drug Treatment Revenue Share by Clinical Stage in 2021
    Figure 44. Global Oncolytic Virus Drug Treatment Market Share Forecast by Clinical Stage (2023-2028)
    Figure 45. Global Oncolytic Virus Drug Treatment Revenue Share by Application in 2021
    Figure 46. Global Oncolytic Virus Drug Treatment Market Share Forecast by Application (2023-2028)
    Figure 47. North America Oncolytic Virus Drug Treatment Sales Market Share by Clinical Stage (2017-2028)
    Figure 48. North America Oncolytic Virus Drug Treatment Sales Market Share by Application (2017-2028)
    Figure 49. North America Oncolytic Virus Drug Treatment Revenue Market Share by Country (2017-2028)
    Figure 50. United States Oncolytic Virus Drug Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 51. Canada Oncolytic Virus Drug Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 52. Mexico Oncolytic Virus Drug Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 53. Europe Oncolytic Virus Drug Treatment Sales Market Share by Clinical Stage (2017-2028)
    Figure 54. Europe Oncolytic Virus Drug Treatment Sales Market Share by Application (2017-2028)
    Figure 55. Europe Oncolytic Virus Drug Treatment Revenue Market Share by Country (2017-2028)
    Figure 56. Germany Oncolytic Virus Drug Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 57. France Oncolytic Virus Drug Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 58. United Kingdom Oncolytic Virus Drug Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 59. Russia Oncolytic Virus Drug Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 60. Italy Oncolytic Virus Drug Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 61. Asia-Pacific Oncolytic Virus Drug Treatment Sales Market Share by Clinical Stage (2017-2028)
    Figure 62. Asia-Pacific Oncolytic Virus Drug Treatment Sales Market Share by Application (2017-2028)
    Figure 63. Asia-Pacific Oncolytic Virus Drug Treatment Revenue Market Share by Region (2017-2028)
    Figure 64. China Oncolytic Virus Drug Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 65. Japan Oncolytic Virus Drug Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 66. South Korea Oncolytic Virus Drug Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 67. India Oncolytic Virus Drug Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 68. Southeast Asia Oncolytic Virus Drug Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 69. Australia Oncolytic Virus Drug Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 70. South America Oncolytic Virus Drug Treatment Sales Market Share by Clinical Stage (2017-2028)
    Figure 71. South America Oncolytic Virus Drug Treatment Sales Market Share by Application (2017-2028)
    Figure 72. South America Oncolytic Virus Drug Treatment Revenue Market Share by Country (2017-2028)
    Figure 73. Brazil Oncolytic Virus Drug Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 74. Argentina Oncolytic Virus Drug Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 75. Middle East and Africa Oncolytic Virus Drug Treatment Sales Market Share by Clinical Stage (2017-2028)
    Figure 76. Middle East and Africa Oncolytic Virus Drug Treatment Sales Market Share by Application (2017-2028)
    Figure 77. Middle East and Africa Oncolytic Virus Drug Treatment Revenue Market Share by Country (2017-2028)
    Figure 78. Turkey Oncolytic Virus Drug Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 79. Saudi Arabia Oncolytic Virus Drug Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 80. UAE Oncolytic Virus Drug Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 81. Methodology
    Figure 82. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Amgen
Oncolytics Biotech
Viralytics
Transgene SA
Oncolys BioPharma
Targovax
PsiOxus Therapeutics
SillaJen Biotherapeutics
Sorrento Therapeutics
Lokon Pharma
Genelux Corporation
Vyriad
TILT Biotherapeutics
Cold Genesys

Related Reports

Global Oncolytic Virus Drug Treatment Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Oncolytic Virus Drug Treatment Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 27 Feb 2023

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Oncolytic Virus Drug Treatment market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Global Oncolytic Virus Drug Treatment Supply, Demand and Key Producers, 2023-2029

Global Oncolytic Virus Drug Treatment Supply, Demand and Key Producers, 2023-2029

date 06 Feb 2023

date Pharma & Healthcare

The global Oncolytic Virus Drug Treatment market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Oncolytic Virus Drug Treatment Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Oncolytic Virus Drug Treatment Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 06 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Oncolytic Virus Drug Treatment market size was valued at USD 6 million in 2023 and is forecast to a readjusted size of USD 28 million by 2030 with a CAGR of 23.8% during review period.

Global Oncolytic Virus Drug Treatment Supply, Demand and Key Producers, 2024-2030

Global Oncolytic Virus Drug Treatment Supply, Demand and Key Producers, 2024-2030

date 27 Feb 2024

date Pharma & Healthcare

The global Oncolytic Virus Drug Treatment market size is expected to reach $ 28 million by 2030, rising at a market growth of 23.8% CAGR during the forecast period (2024-2030).

Product Tags

oncolytic virus drug treatment

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>